The objective of this paper is to review the literature on the use of
prodrugs to overcome the drug delivery obstacles associated with phosp
hate, phosphonate and phosphinate functional group-containing drugs. T
his is an important area of research because, although we have been su
ccessful at identifying numerous phosphate and phosphonate functional
group-containing drugs as antiviral and anticancer agents, as well as
for other uses, our ability to orally deliver these drugs and to targe
t them to desired sites has led to limtied success. Various acyloxymet
hyl- and aryl-ester prodrugs have shown promise. Alternative and imagi
native approaches may be necessary before complete success is realized
. It is our hope that this review will stimulate further innovative pr
odrug research into overcoming the barriers to the delivery of these i
mportant drugs.